RXST

insider transactions

RxSight, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

+339

10.0K buy · 9.7K sell

Net value · 365d

$68.7K

$199.8K in · $131.1K out

Sentiment · 365d

Net buying

60% buying · 40% selling

Open-market trades · 365d

10.0K buy · 9.7K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 17, 26

Robert Keith Warner

Director

—

37.0K sh

Own +90%
Grant·A
Jun 17, 26

Bakker Juliet Tammenoms

Director

—

37.0K sh

Own +77%
Grant·A
Jun 17, 26

PALMISANO ROBERT J

Director

—

37.0K sh

Own +90%
Grant·A
Jun 17, 26

Jesse Anderson Corley

Director

—

37.0K sh

Own +75%
Grant·A
Jun 17, 26

Raymond W Cohen

Director

—

30.9K sh

Own +87%
Grant·A
Jun 17, 26

Julie Andrews

Director

—

37.0K sh

Own +90%
Exercise·M
Apr 17, 26

Ilya Goldshleger

Chief Operating Officer

$0

12.5K sh

Own New
Exercise·M
Apr 17, 26

Ilya Goldshleger

Chief Operating Officer

$51.6K

12.5K sh · $4.13

Own +19%
Buy·P
Mar 26, 26

Raymond W Cohen

Director

$199.8K

10.0K sh · $19.98

Own +24%
Sell·S
Mar 5, 26

Julie Andrews KEY

CFO

$29.7K

2.4K sh · $12.55

Own -3%
Sell·S
Mar 4, 26

Julie Andrews KEY

CFO

$31.3K

2.4K sh · $12.92

Own -3%
Grant·A
Mar 3, 26

Julie Andrews KEY

CFO

$0

84.3K sh

Own New
Grant·A
Mar 3, 26

Julie Andrews KEY

CFO

$0

35.5K sh

Own +61%
Exercise·M
Feb 28, 26

Mark Wilterding KEY

Chief Financial Officer

$0

20.4K sh

Own +17%
Other·F
Feb 28, 26

Mark Wilterding KEY

Chief Financial Officer

$61.4K

8.1K sh · $7.61

Own -39%
Exercise·M
Feb 28, 26

Mark Wilterding KEY

Chief Financial Officer

—

20.4K sh

Own New
Exercise·M
Feb 28, 26

Scott Gaines

Chief Customer Officer

$0

1.7K sh

Own +20%
Exercise·M
Feb 28, 26

Scott Gaines

Chief Customer Officer

$0

1.2K sh

Own +25%
Exercise·M
Feb 28, 26

Scott Gaines

Chief Customer Officer

$0

604 sh

Own +33%
Exercise·M
Feb 28, 26

Scott Gaines

Chief Customer Officer

$0

1.5K sh

Own +100%
Other·F
Feb 28, 26

Scott Gaines

Chief Customer Officer

$19.6K

2.6K sh · $7.61

Own -15%
Exercise·M
Feb 28, 26

Scott Gaines

Chief Customer Officer

—

6.3K sh

Own +56%
Grant·A
Feb 27, 26

Eric Weinberg

Exhibit 24 - Power of Attorne…

$0

32.2K sh

Own New
Grant·A
Feb 27, 26

Ronald M Kurtz MD KEY

President & CEO

$0

80.5K sh

Own New
Grant·A
Feb 27, 26

Ilya Goldshleger

Chief Operating Officer

$0

32.2K sh

Own New
Grant·A
Feb 27, 26

Scott Gaines

Chief Customer Officer

$0

32.2K sh

Own New
Sell·S
Jan 16, 26

Julie Andrews KEY

CFO

$70.1K

4.9K sh · $14.38

Own -8%
Grant·A
Jan 14, 26

Raymond W Cohen

Director

$0

44.0K sh

Own +91%
Grant·A
Jan 12, 26

Mark Wilterding KEY

Chief Financial Officer

$0

163.5K sh

Own New
Grant·A
Jan 12, 26

Mark Wilterding KEY

Chief Financial Officer

$0

258.8K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 17, 2026	Robert Keith Warner	Director	Grant A	37.0K	+90%	—	—
Jun 17, 2026	Bakker Juliet Tammenoms	Director	Grant A	37.0K	+77%	—	—
Jun 17, 2026	PALMISANO ROBERT J	Director	Grant A	37.0K	+90%	—	—
Jun 17, 2026	Jesse Anderson Corley	Director	Grant A	37.0K	+75%	—	—
Jun 17, 2026	Raymond W Cohen	Director	Grant A	30.9K	+87%	—	—
Jun 17, 2026	Julie Andrews	Director	Grant A	37.0K	+90%	—	—
Apr 17, 2026	Ilya Goldshleger	Chief Operating Officer	Exercise M	12.5K	New	—	$0
Apr 17, 2026	Ilya Goldshleger	Chief Operating Officer	Exercise M	12.5K	+19%	$4.13	$51.6K
Mar 26, 2026	Raymond W Cohen	Director	Buy P	10.0K	+24%	$19.98	$199.8K
Mar 5, 2026	Julie Andrews KEY	CFO	Sell S	2.4K	-3%	$12.55	$29.7K
Mar 4, 2026	Julie Andrews KEY	CFO	Sell S	2.4K	-3%	$12.92	$31.3K
Mar 3, 2026	Julie Andrews KEY	CFO	Grant A	84.3K	New	—	$0
Mar 3, 2026	Julie Andrews KEY	CFO	Grant A	35.5K	+61%	—	$0
Feb 28, 2026	Mark Wilterding KEY	Chief Financial Officer	Exercise M	20.4K	+17%	—	$0
Feb 28, 2026	Mark Wilterding KEY	Chief Financial Officer	Other F	8.1K	-39%	$7.61	$61.4K
Feb 28, 2026	Mark Wilterding KEY	Chief Financial Officer	Exercise M	20.4K	New	—	—
Feb 28, 2026	Scott Gaines	Chief Customer Officer	Exercise M	1.7K	+20%	—	$0
Feb 28, 2026	Scott Gaines	Chief Customer Officer	Exercise M	1.2K	+25%	—	$0
Feb 28, 2026	Scott Gaines	Chief Customer Officer	Exercise M	604	+33%	—	$0
Feb 28, 2026	Scott Gaines	Chief Customer Officer	Exercise M	1.5K	+100%	—	$0
Feb 28, 2026	Scott Gaines	Chief Customer Officer	Other F	2.6K	-15%	$7.61	$19.6K
Feb 28, 2026	Scott Gaines	Chief Customer Officer	Exercise M	6.3K	+56%	—	—
Feb 27, 2026	Eric Weinberg	Exhibit 24 - Power of Attorney Chief Business Development Officer	Grant A	32.2K	New	—	$0
Feb 27, 2026	Ronald M Kurtz MD KEY	President & CEO	Grant A	80.5K	New	—	$0
Feb 27, 2026	Ilya Goldshleger	Chief Operating Officer	Grant A	32.2K	New	—	$0
Feb 27, 2026	Scott Gaines	Chief Customer Officer	Grant A	32.2K	New	—	$0
Jan 16, 2026	Julie Andrews KEY	CFO	Sell S	4.9K	-8%	$14.38	$70.1K
Jan 14, 2026	Raymond W Cohen	Director	Grant A	44.0K	+91%	—	$0
Jan 12, 2026	Mark Wilterding KEY	Chief Financial Officer	Grant A	163.5K	New	—	$0
Jan 12, 2026	Mark Wilterding KEY	Chief Financial Officer	Grant A	258.8K	New	—	$0

About RXST insider trading

This page tracks insider transactions for RxSight, Inc. (RXST) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.